Chemical Structure (Estradiol Figure 1)
Estradiol Film, Extended Release
Product Images NDC 50090-7610
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 50090-7610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure D (Estradiol Figure 10)
Figure E, F (Estradiol Figure 11)
Figure G (Estradiol Figure 12)
Layers (Estradiol Figure 2)
This text mentions an adhesive containing Estradiol and a protective liner. The adhesive likely refers to a medical product designed to stick onto the skin containing Estradiol, which is a hormone important in the female reproductive system. The protective liner could be a part of the packaging or application process to protect the adhesive until it is ready to be used.*
Figure1 (Estradiol Figure 3)
This text provides information about serum concentration levels measured in pg/mL over different time points (days) with varying dosages of A (0.1 mg per day, 0.05 mg per day, and 0.25 mg per day).*
Figure2 (Estradiol Figure 4)
This text appears to be showing results from a study comparing the effects of Vivelle (0.0375 mg/day) on an unknown outcome against a placebo. The weeks labeled 4, 8, and 12 likely represent different time points during the study where measurements were taken. Additionally, statistical significance was found between Vivelle and placebo with a significance level of p<0.05. Results for different variables at each time point are presented in the text, although the exact nature of these variables is not provided.*
Figure3 (Estradiol Figure 5)
This appears to be a table showing the percentage change from baseline for different treatment options over various weeks up to week 104. The treatments mentioned include Vivelle 0.1mg/day, Vivelle 0.025mg/day, Vivelle 0.05mg/day, placebo, and Vivelle 0.0375mg/day. The data seems to be analyzing the effects or outcomes of these treatments over time.*
Figure4 (Estradiol Figure 6)
The text provides information on the treatment duration and results of a study involving different doses of Vivelle patches over the course of 104 weeks. It shows comparisons between the different doses and a placebo, as well as percentage changes from baseline at specific time points during the study. The text also includes statistical significance values for the comparisons made.*
Figure A (Estradiol Figure 7)
Figure B (Estradiol Figure 8)
Figure C (Estradiol Figure 9)
Label Image (Lbl500907610)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
